Role of purine biosynthesis in bacillus anthracis pathogenesis and virulence

Infection and Immunity

Volumn 79, Issue 1, 2011, Pages 153-166

  Jenkins, Amy ^a   Cote, Christopher ^a   Twenhafel, Nancy ^a   Merkel, Tod ^b   Bozue, Joel ^a   Welkos, Susan ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; PURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SPORE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; EXPERIMENTAL GUINEA PIG; EXPERIMENTAL RABBIT; FEMALE; GENE IDENTIFICATION; GENETIC COMPLEMENTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURH GENE; PURINE SYNTHESIS; SPORE GERMINATION; WILD TYPE;

ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GUINEA PIGS; MICE; PURINES; RABBITS; TIME FACTORS; VIRULENCE;

EID: 78650893958     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00925-10     Document Type: Article

References (72)

1. Aiba, A., and K. Mizobuchi. 1989. Nucleotide sequence analysis of genes purH and purD involved in the de novo purine nucleotide biosynthesis of Escherichia coli. J. Biol. Chem. 264:21239-21246.
2. Allen, S., J. L. Zilles, and D. M. Downs. 2002. Metabolic flux in both the purine mononucleotide and histidine biosynthetic pathways can influence synthesis of the hydroxymethyl pyrimidine moiety of thiamine in Salmonella enterica. J. Bacteriol. 184:6130-6137.
3. Beaman, T. C., A. D. Hitchins, K. Ochi, N. Vasantha, T. Endo, and E. Freese. 1983. Specificity and control of uptake of purines and other compounds in Bacillus subtilis. J. Bacteriol. 156:1107-1117.
4. Beedham, R. J., P. C. Turnbull, and E. D. Williamson. 2001. Passive transfer of protection against Bacillus anthracis infection in a murine model. Vaccine 19:4409-4416.
5. Bennett, E. L. 1953. Incorporation of adenine into nucleotides and nucleic acids of C57 mice. Biochim. Biophys. Acta 11:487-496.
6. Bozue, J., C. K. Cote, K. L. Moody, and S. L. Welkos. 2007. Fully virulent Bacillus anthracis does not require the immunodominant protein, BclA, for pathogenesis. Infect. Immun. 75:508-511.
7. Bozue, J. A., N. Parthasarathy, L. R. Phillips, C. K. Cote, P. F. Fellows, I. Mendelson, A. Shafferman, and A. M. Friedlander. 2005. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs. Microb. Pathog. 38:1-12.
8. Brubaker, R. R. 1970. Interconversion of purine mononucleotides in Pasteu-rella pestis. Infect. Immun. 1:446-454.
9. Burrows, T. W., and W. A. Gillett. 1971. Host specificity of Brazilian strains of Pasteurella pestis. Nature 229:51-52.
10. Carnrot, C., L. Wang, D. Topalis, and S. Eriksson. 2008. Mechanisms of substrate selectivity for Bacillus anthracis thymidylate kinase. Protein Sci. 17:1486-1493.
11. Cataldi, A., M. Mock, and L. Bentancor. 2000. Characterization of Bacillus anthracis strains used for vaccination. J. Appl. Microbiol. 88:648-654.
12. Chatterjee, S., and R. V. Sonti. 2005. Virulence deficiency caused by a transposon insertion in the purH gene of Xanthomonas oryzae pv. oryzae. Can. J. Microbiol. 51:575-581.
13. Cote, C. K., J. Bozue, K. L. Moody, T. L. DiMezzo, C. E. Chapman, and S. L. Welkos. 2008. Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization. Microbiology 154:619-632.
14. Cote, C. K., J. Bozue, N. Twenhafel, and S. L. Welkos. 2009. Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model. J. Med. Microbiol. 58:816-825.
15. Cote, C. K., C. A. Rossi, A. S. Kang, P. R. Morrow, J. S. Lee, and S. L. Welkos. 2005. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb. Pathog. 38:209-225.
16. Cote, C. K., N. van Rooijen, and S. L. Welkos. 2006. The roles of macro-phages and neutrophils in the early host response to Bacillus anthracis spores using a mouse model of infection. Infect. Immun. 74:469-480.
17. Dixon, W. J. 1965. The up-and-down method for small samples. J. Am. Stat. Assn. 60:967-978.
18. Duong, S., L. Chiaraviglio, and J. E. Kirby. 2006. Histopathology in a murine model of anthrax. Int. J. Exp. Pathol. 87:131-137.
19. Ebbole, D. J., and H. Zalkin. 1989. Bacillus subtilis pur operon expression and regulation. J. Bacteriol. 171:2136-2141.
20. Ebbole, D. J., and H. Zalkin. 1987. Cloning and characterization of a 12-gene cluster from Bacillus subtilis encoding nine enzymes for de novo purine nucleotide synthesis. J. Biol. Chem. 262:8274-8287.
21. Endo, T., B. Uratani, and E. Freese. 1983. Purine salvage pathways of Bacillus subtilis and effect of guanine on growth of GMP reductase mutants. J. Bacteriol. 155:169-179.
22. Fellows, P. F., M. K. Linscott, B. E. Ivins, M. L. Pitt, C. A. Rossi, P. H. Gibbs, and A. M. Friedlander. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19:3241-3247.
23. Firoved, A. M., G. F. Miller, M. Moayeri, R. Kakkar, Y. Shen, J. F. Wiggins, E. M. McNally, W. J. Tang, and S. H. Leppla. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167:1309-1320.
24. Flannigan, K. A., S. H. Hennigan, H. H. Vogelbacker, J. S. Gots, and J. M. Smith. 1990. Purine biosynthesis in Escherichia coli K12: structure and DNA sequence studies of thepurHD locus. Mol. Microbiol. 4:381-392.
25. Friedlander, A. M. 2000. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Curr. Clin. Top. Infect. Dis. 20:335-349.
26. Grenha, R., V. M. Levdikov, M. J. Fogg, E. V. Blagova, J. A. Brannigan, A. J. Wilkinson, and K. S. Wilson. 2005. Structure of purine nucleoside phosphor-ylase (DeoD) from Bacillus anthracis. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61:459-462.
27. Grinberg, L. M., F. A. Abramova, O. V. Yampolskaya, D. H. Walker, and J. H. Smith. 2001. Quantitative pathology of inhalational anthrax. I. Quantitative microscopic findings. Mod. Pathol. 14:482-495.
28. Headrick, J. P., J. Peart, B. Hack, B. Garnham, and G. P. Matherne. 2001. 5'-Adenosine monophosphate and adenosine metabolism, and adenosine responses in mouse, rat and guinea pig heart. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 130:615-631.
29. Hoiseth, S. K., and B. A. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
30. Ivanovics, G., E. Marjai, and A. Dobozy. 1968. The growth of purine mutants of Bacillus anthracis in the body of the mouse. J. Gen. Microbiol. 53:147-162.
31. Ivins, B., P. Fellows, L. Pitt, J. Estep, J. Farchaus, A. Friedlander, and P. Gibbs. 1995. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine 13:1779-1784.
32. Ivins, B. E., P. F. Fellows, and G. O. Nelson. 1994. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs. Vaccine 12:872-874.
33. Ivins, B. E., S. L. Welkos, G. B. Knudson, and S. F. Little. 1990. Immunization against anthrax with aromatic compound-dependent (Aro~) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect. Immun. 58:303-308.
34. Jarvis, S. M., J. R. Hammond, A. R. Paterson, and A. S. Clanachan. 1982. Species differences in nucleoside transport. A study of uridine transport and nitrobenzylthioinosine binding by mammalian erythrocytes. Biochem. J. 208: 83-88.
35. Johansen, L. E., P. Nygaard, C. Lassen, Y. Agerso, and H. H. Saxild. 2003. Definition of a second Bacillus subtilis pur regulon comprising the pur and xpt-pbuX operons plus pbuG, nupG (yxjA), and pbuE (ydhL). J. Bacteriol. 185:5200-5209.
36. Kappock, T. J., S. E. Ealick, and J. Stubbe. 2000. Modular evolution of the purine biosynthetic pathway. Curr. Opin. Chem. Biol. 4:567-572.
37. Kim, Y. R., S. E. Lee, C. M. Kim, S. Y. Kim, E. K. Shin, D. H. Shin, S. S. Chung, H. E. Choy, A. Progulske-Fox, J. D. Hillman, M. Handfield, and J. H. Rhee. 2003. Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect. Immun. 71: 5461-5471.
38. Klarsfeld, A. D., P. L. Goossens, and P. Cossart. 1994. Five Listeria monocytogenes genes preferentially expressed in infected mammalian cells: plcA, purH,purD,pyrE and an arginine ABC transporter gene, arpJ. Mol. Microbiol. 13:585-597.
39. Kuo, S. R., M. C. Willingham, S. H. Bour, E. A. Andreas, S. K. Park, C. Jackson, N. S. Duesbery, S. H. Leppla, W. J. Tang, and A. E. Frankel. 2008. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb. Pathog. 44:467-472.
40. Little, S. F., and G. B. Knudson. 1986. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect. Immun. 52:509-512.
41. Lu, S., C. D. Smith, Z. Yang, P. S. Pruett, L. Nagy, D. McCombs, L. J. Delucas, W. J. Brouillette, and C. G. Brouillette. 2008. Structure of nicotinic acid mononucleotide adenylyltransferase from Bacillus anthracis. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64:893-898.
42. Lyons, C. R., J. Lovchik, J. Hutt, M. F. Lipscomb, E. Wang, S. Heninger, L. Berliba, and K. Garrison. 2004. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect. Immun. 72:4801-4809.
43. Marquis, H., H. G. Bouwer, D. J. Hinrichs, and D. A. Portnoy. 1993. Intra-cytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants. Infect. Immun. 61:3756-3760.
44. May, M., S. Mehboob, D. C. Mulhearn, Z. Wang, H. Yu, G. R. Thatcher, B. D. Santarsiero, M. E. Johnson, and A. D. Mesecar. 2007. Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design. J. Mol. Biol. 371:1219-1237.
45. McFarland, W. C, and B. A. Stocker. 1987. Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb. Pathog. 3:129-141.
46. McMurry, J., and T. P. Begley. 2005. The organic chemistry of biological pathways. Roberts and Company Publishers, Englewood, CO.
47. Mei, J. M., F. Nourbakhsh, C. W. Ford, and D. W. Holden. 1997. Identification of Staphylococcus aureus virulence genes in a murine model of bacter-aemia using signature-tagged mutagenesis. Mol. Microbiol. 26:399-407.
48. Meier, C, L. G. Carter, S. Sainsbury, E. J. Mancini, R. J. Owens, D. I. Stuart, and R. M. Esnouf. 2008. The crystal structure of UMP kinase from Bacillus anthracis (BA1797) reveals an allosteric nucleotide-binding site. J. Mol. Biol. 381:1098-1105.
49. Mendelson, I., S. Tobery, A. Scorpio, J. Bozue, A. Shafferman, and A. M. Friedlander. 2004. The NheA component of the non-hemolytic enterotoxin of Bacillus cereus is produced by Bacillus anthracis but is not required for virulence. Microb. Pathog. 37:149-154.
50. Meyer, E., T. J. Kappock, C. Osuji, and J. Stubbe. 1999. Evidence for the direct transfer of the carboxylate of N5-carboxyaminoimidazole ribonucle-otide (N5-CAIR) to generate 4-carboxy-5-aminoimidazole ribonucleotide catalyzed by Escherichia coli PurE, an N5-CAIR mutase. Biochemistry 38: 3012-3018.
51. Meyer, K. F., G. Smith, L. Foster, M. Brookman, and M. Sung. 1974. Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs. J. Infect. Dis. 129(Suppl.):S85-S112.
52. Mock, M., and A. Fouet. 2001. Anthrax. Annu. Rev. Microbiol. 55:647-671.
53. Moir, A., and D. Smith. 1990. The genetics of bacterial spore germination. Annu. Rev. Microbiol. 44:531-553.
54. Nicely, N. I., D. Parsonage, C. Paige, G. L. Newton, R. C. Fahey, R. Leonardi, S. Jackowski, T. C. Mallett, and A. Claiborne. 2007. Structure of the type III pantothenate kinase from Bacillus anthracis at 2.0 Å resolution: implications for coenzyme A-dependent redox biology. Biochemistry 46:3234-3245.
55. Oyston, P. C., P. Russell, E. D. Williamson, and R. W. Titball. 1996. An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in mice. Microbiology 142(Pt. 7):1847-1853.
56. Patching, S. G., S. A. Baldwin, A. D. Baldwin, J. D. Young, M. P. Gallagher, P. J. Henderson, and R. B. Herbert. 2005. The nucleoside transport proteins, NupC and NupG, from Escherichia coli: specific structural motifs necessary for the binding of ligands. Org. Biomol. Chem. 3:462-470.
57. Perez-Casal, J., M. G. Caparon, and J. R. Scott. 1991. Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J. Bacteriol. 173:2617-2624.
58. Philips, F. S., J. B. Thiersch, and A. Bendich. 1952. Adenine intoxication in relation to in vivo formation and deposition of 2,8-dioxyadenine in renal tubules. J. Pharmacol. Exp. Ther. 104:20-30.
59. Polissi, A., A. Pontiggia, G. Feger, M. Altieri, H. Mottl, L. Ferrari, and D. Simon. 1998. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. 66:5620-5629.
60. Ristroph, J. D., and B. E. Ivins. 1983. Elaboration of Bacillus anthracis antigens in a new, defined culture medium. Infect. Immun. 39:483-486.
61. Samant, S., H. Lee, M. Ghassemi, J. Chen, J. L. Cook, A. S. Mankin, and A. A. Neyfakh. 2008. Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog. 4:e37.
62. Schwarz, M. R., and W. O. Rieke. 1963. The utilization in vivo of mouse nucleic acid metabolites labeled with radioactive precursor substances. Lab. Invest. 12:92-101.
63. Stocker, B. A., S. K. Hoiseth, and B. P. Smith. 1983. Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves. Dev. Biol. Stand. 53:47-54.
64. Twenhafel, N. A., E. Leffel, and M. L. Pitt. 2007. Pathology of inhalational anthrax infection in the African green monkey. Vet. Pathol. 44:716-721.
65. Vasconcelos, D., R. Barnewall, M. Babin, R. Hunt, J. Estep, C. Nielsen, R. Carnes, and J. Carney. 2003. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab. Invest. 83:1201-1209.
66. Welkos, S. L. 1991. Plasmid-associated virulence factors of non-toxigenic (pX01-) Bacillus anthracis. Microb. Pathog. 10:183-198.
67. Welkos, S. L., D. Becker, A. Friedlander, and R. Trotter. 1990. Pathogenesis and host resistance to Bacillus anthracis: a mouse model. Salisbury Med. Bull. 68:49-52.
68. Welkos, S. L., T. J. Keener, and P. H. Gibbs. 1986. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51:795-800.
69. Welkos, S. L., R. W. Trotter, D. M. Becker, and G. O. Nelson. 1989. Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microb. Pathog. 7:15-35.
70. Welkos, S. L., N. J. Vietri, and P. H. Gibbs. 1993. Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence. Microb. Pathog. 14:381-388.
71. Zaucha, G. M., L. M. Pitt, J. Estep, B. E. Ivins, and A. M. Friedlander. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 122:982-992.
72. Zhang, Y., M. Morar, and S. E. Ealick. 2008. Structural biology of the purine biosynthetic pathway. Cell. Mol. Life Sci. 65:3699-3724.